Search results
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Market Watch· 8 hours agojumped more than 30% Monday morning after the health and wellness platform said it would offer...
All About Ozempic and the Next Generation of Obesity Drugs
New York Times· 15 hours agoOzempic belongs to a class of medications called GLP-1 receptor agonists, named after a hormone in...
Wegovy weight loss benefits sustained for 4 years, doubling prior estimates
MedicalNewsToday via AOL· 6 hours agoA new study shows that Wegovy remains effective for losing weight and maintaining weight loss for at...
Apple Juice Sold At Kroger, Publix, Target, And Winn-Dixie Recalled Over High Arsenic Levels
SouthernLiving· 7 hours agoMartinelli's voluntarily recalled a single lot of its apple juice last month after samples tested...
New study focuses on what happens if you stay on weight loss drug Wegovy for years
Good Morning America via Yahoo News· 6 hours agoAmid the growing popularity of drugs used for weight loss like Ozempic, Wegovy, Mounjaro and...
Drugs advertised as alternatives to Ozempic, Wegovy posing health risks
WCVB Boston· 3 hours agoWeogvy and Ozempic have been hailed as a diabetes breakthrough, as the drugs mimic a digestive...
CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF...
WKRN Nashville· 9 hours agoFood and Drug Administration (FDA) has granted Orphan Drug Designation to Cantex' azeliragon, a ...
High price of Ozempic, other diabetes drugs deprive low-income people of effective treatment
CBS News· 16 hours agoFor the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes,...
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
InvestorPlace· 5 hours agoHims & Hers has partnered with an undisclosed manufacturer of generic and 503B compounded injectable...
Hims & Hers is now selling Ozempic-like weight loss drugs for $199
Quartz· 9 hours agoThe millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering...